The study seeks to show that interscalene injection of a small volume (<8ml) of ropivacaine
at a low concentration (0.1%) reduces the frequency of hemi-diaphragmatic paresis compared to
low volume injection at the standard concentration (0.5%) in patients undergoing arthroscopic
shoulder surgery with ISB.